Research programme: spinal cord injuries therapeutics - Kidswell Bio/Nagoya University
Alternative Names: Spinal cord injuries therapeutics - Kidswell Bio/Nagoya UniversityLatest Information Update: 27 Jun 2024
At a glance
- Originator Kidswell Bio; Nagoya University
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Spinal cord injuries
Most Recent Events
- 27 Jun 2024 Spinal cord injuries therapeutics is still in Spinal-cord-injuries in Japan (Parenteral) (Kidswell Bio pipeline, June 2024)
- 28 Apr 2024 No recent reports of development identified for research development in Spinal-cord-injuries in Japan (Parenteral)
- 01 Jul 2021 Gene Techno Science is now called Kidswell Bio